A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2002
10/17/2002	WO2002049626A3 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
10/17/2002	WO2002047493A3 Health promoting compositions
10/17/2002	WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002	WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2002007772A3 Improved oral dosage formulations
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151986 Method, Instruments,and kit for autologous tansplantation
10/17/2002	US20020151876 Devices and methods for management of bone density
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002	US20020151573 Anticancer agents
10/17/2002	US20020151572 Nitric oxide synthase (NOS); alone or in combination with another active agent for the treatment of psoriasis, an antiinflammatory, an analgesic, a cognition enhancer or sleep disorder treatment
10/17/2002	US20020151569 Peroxisome Proliferator Activated Receptors (PPARs) antagonists 4-oxo-5-thiazolidine acetamide derivatives
10/17/2002	US20020151560 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/17/2002	US20020151558 Triazolo compounds as MMP inhibitors
10/17/2002	US20020151555 Pyrimidine matrix metalloproteinase inhibitors
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151547 Substituted phenyl-piperidine methanone compounds
10/17/2002	US20020151530 Administering to a woman, undergoing estrogen replacement therapy for treating homonal deficiences, continuously and uninterruptedly, a therapeutic effective amount of both estrogen and a non-aromatizing androgen in daily dosage
10/17/2002	US20020151528 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151501 Compounds having growth hormone releasing activity
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150753 Porous, biodegradable polymer; tissue culture
10/17/2002	US20020150638 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/17/2002	US20020150624 Mixture of drug, aminoacrylate polymer and acid
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002	CA2699611A1 Desaturase genes and uses thereof
10/17/2002	CA2698579A1 Desaturase genes and uses thereof
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443378A1 Methods of screening and using inhibitors of angiogenesis
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443294A1 Remedies for infant chronic arthritis-relating diseases
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2442996A1 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	CA2442964A1 Improved anti-inflammatory herbal composition and method of use
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442685A1 Estrogen receptor-related receptor alpha (err.alpha.) and cartilage formation
10/17/2002	CA2441538A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002	EP1248847A1 Irak-4: compositions and methods of use
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248781A1 Pyrazole cyclic amp-specific pde inhibitors
10/16/2002	EP1248776A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
10/16/2002	EP1248630A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
10/16/2002	EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP1248604A2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
10/16/2002	EP1248602A2 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0949927B1 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	CN1374967A Compounds for the treatment of ischemia
10/16/2002	CN1374961A Azepinoindole derivatives, the production and use thereof
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374863A Bicyclic antagonists selective for the alpha beta integrin
10/16/2002	CN1374839A Potassium calcium citrate compositions and methods for production
10/16/2002	CN1374320A HAb18G(/CD147) peptide agonist and its prepn and use
10/16/2002	CN1374122A Bone-setting silky fowl ointment for treating osteological diseases and its prepn and application
10/16/2002	CN1374118A Chinese medicine for treating ache tendon and vessel and numb limbs and its prepn process
10/16/2002	CN1374085A Externally used and ophthalmic gel prepn of levo ofloxacin
10/16/2002	CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/15/2002	US6465687 Thyroid receptor ligands and method
10/15/2002	US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002	US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002	US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002	US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465471 Cinnamic acid derivatives
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	US6464729 Reconstituted mineralized cartilage tissue
10/15/2002	CA2264685C 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
10/15/2002	CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002	CA2071912C Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
10/10/2002	WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor

1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 820